Document Type : Research Paper

Authors

1 Central Health Laboratories in Baghdad

2 Department of Biology, College of Science, Baghdad University.Baghdad,Iraq.

10.37652/juaps.2010.15523

Abstract

Fourteen thousand, five hundred and two sera of patients from sixteen governorates in Iraq ,suspected to be parasitized by Leishmania donovani, have been tested during the period January 2000 to December 2002, by indirect fluorescent antibody test (IFAT) using a leptomonad antigen. A total of 5558(38.5%) cases of them were found positive for IFAT for visceral leishmaniasis (VL). The most common age group infected with VL was between 1- 5 years; they represented 5390 (96.97 %). The highest ratio of VL infections was in February and January; they represented 510 positive cases in February 2000, 417 in January 2001 and 513 in February 2002. It was seems that Wasit governorate had the highest percentage of infections; it was 35 %, 29.6 % and 33 % in 2000, 2001 and 2002 respectively, then it follows by Diala, Babil and Baghdad governorates

Keywords

Main Subjects

(1) Marquardt, W.C., Demaree,   R.S. and Grieve, R.B.( 2000). Parasitology and   vector biology. 2nd edition.Academic Press, USA,        702p.
 (2) Neouimine, N.I. (1996). Leishmaniasis in the Eastern Mediterranean region. East     Mediterranean Health J.  V. 1, P. 94-101.
(3) Magill, A.J. (1995). Epidemiology of the leishmaniasis. Dermatol. Clin. V. 3 (3), P. 505-523.
(4) Fernandez-Guerrero, M.L., Robles, P., Rivas, P., Mojer, F., Muniz, G. and Gorgolas, M. (2004).Visceral leishmaniasis in immuno-compromised patients with and without AIDS: a comparison of clinical features and prognosis. Acta. Trop. V. 90 (1), P. 11-16.
(5) Walker, M., Kublin, J.C. and Zunt, J.R. (2006). Parasitic central nervous system infections in immunocomprised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis. Clin. Infect. Dis. V. 42(1), P. 115-125.
(6) Korzeniewski, K. and Olszanski, R.( 2004). Leishmaniasis among soldiers of stabilization forces in Iraq. Review article. Int. Marit. Health. V. 55 (1-4), P. 155-163.
(7) Choi, C.M. and Lerner, E.A. (2001). Leishmaniasis as an emerging infection. J. Investig, Dermatol. Symp. Proc. V. 6(3) P.175-182.
(8) Bucheton, B., El-Safi, S.H., Hammad, A., Kheir, M.M., Eudes, N., Dessein, A.J. and Mary, C. (2003). Antileishmanial antibodies in an outbreak of visceral leishmaniasis in eastern Sudan: high antibody responses occur in resistant subjects and are not predictive of disease. Trans. Roy. Soc. Trop. Med. Hyg. V. 97(4), P. 463-468.
(9) Mayrink, W., Araujo, F.G. and Magalhaes, P.A. (1967). Fluorescent antibody test in visceral leishmanaiasis. 1- Sensitivity of the test. Rev. Inst. Med. Trop. Sao Paulo. V. 9(3) P.172-174.
(10) Duxbury, R.E. and Sadun, E.H. (1964). Fluorescent antibody technique for the sero-diagnosis of visceral leishmaniasis. Am. J. Trop. Med. Hyg. V. 13, P. 525-529.
(11) Al-Samarai, A.M. and Al-Obaidi, H.S. (2009). Cutaneous leishmaniasis in Iraq. J. Infect. Developing Countries. V. 3(2), P. 123-129.
(12) Aronson, N.E., Sanders, J.W. and Moran, K.A. (2006). In harm’s way: Infections in deployed American military forces. Clin. Infect. Dis. V. 43(8), P. 1045-1051.